3714 research outputs found
Sort by
An update on clinical trials for chemoprevention of human skin cancer
No full textThe pathophysiology of skin cancer is complex, with multiple factors contributing to its development. The proactive treatment of skin cancer has been investigated in the form of chemoprevention of cutaneous malignancies in clinical trials. Chemoprevention is the use of natural or pharmacologic agents that prevent or reverse skin cancer development. Multiple trials have arisen over the past decades to explore the efficacy of specific agents to halt the progression of UV radiation damage. This comprehensive review article aims to assess clinical trials performed with chemopreventive agents for melanoma and nonmelanoma skin cancers. The following compounds were most often used in these trials: nicotinamide, retinoids, polyphenolic antioxidants, COX-2 selective inhibitors, non-steroidal anti-inflammatory drugs, difluoromethylornithine, and 5-fluorouracil. Many agents show promise in their ability to prevent nonmelanoma skin cancer formation, with few melanoma trials demonstrating efficacy. The chemoprevention efforts aimed at skin cancer are complex; current and future trials will be instrumental in identifying therapeutic agents that pose efficacy in halting cancer development and assessing whether long-term administration is tolerable
Use of mHealth for management of hypertension in low and middle-income countries: opportunities and challenges
No full textDespite being the leading cause of global mortality, the hypertension control rate is astonishingly low, particularly in low- and middle-income countries. There is evidence that the mHealth approach is a potential platform for delivering interventions for hypertension management. Our recent study from Nepal also provided strong evidence for reducing blood pressure, improving control rate, and medication adherence. The objective of this paper is to document the real-world experience of designing and implementing a mHealth project in Nepal and relates them with the evidence from other similar Low- and Middle-Income Country (LMIC) settings. We learned that mHealth provides a unique opportunity to bridge the gap between providers and patients, send health education and reminder messages, secure patients' privacy, and make data management easier. We also encountered technological and financial barriers, unclear mHealth policy and guidelines, and low literacy levels, including digital literacy. As many of them are addressable, integrating mHealth provides a promising approach to hypertension management
Enhanced all-climate sodium-ion batteries performance in a low-defect and Na-enriched Prussian blue analogue cathode by nickel substitution
No full textCobalt hexacyanoferrate (CoHCF) is one of the most promising cathode materials for all-climate sodium-ion batteries (SIBs) due to its open three-dimensional (3D) framework structures, high theoretical specific capacity, good voltage platform and almost no Jahn-Teller effects. However, CoHCF still suffers from poor cycling stability and bad rate capability, which is closely related to the huge distortion of frame structure and poor conductivity. In this study, by choosing nickel (Ni) to partially replace cobalt (Co) in the CoHCF lattice, we successfully prepared low-defect and Na-enriched Na2Co0.7Ni0.3[Fe(CN)6] (Co0.7Ni0.3HCF) in chelate and sodium salt-assisted coprecipitation method. Both experiments and first-principles calculations demonstrate that Ni substitution can effectively suppress the lattice distortion during the charging and discharging process of CoHCF. Furthermore, the introduction of Ni increases ion mobility by reducing the ion migration barrier (0.31 eV versus 0.17 eV) and improves the electronic conductivity by reducing the bandgap. It is found that Co0.7Ni0.3HCF exhibits superior electrochemical performance compared with that of CoHCF in a wide temperature range (-30 to 60 °C). At 25 °C, Co0.7Ni0.3HCF delivers a high specific capacity of 142.2 mAh g-1 at 0.2 C, an ultrahigh rate capability with 126.2 mAh g-1 at 5 C and excellent cycling stability with 80.9% capacity retention after 500 cycles at 5 C. Even at -30 °C,Co0.7Ni0.3HCF can provide a high capacity of 109 mAh g-1 without an activation process. This work reveals the great application prospect of PBAs for all-climate SIBs, especially at low temperatures
Use of emerging technologies to help measure fjordic biodiversity and blue carbon: mini-manned submarines and autonomous underwater vehicle swarms
No full textMeaningful protection of global oceans lags far behind that of land and has taken little consideration of climate mitigation potential to date (such as through assessment of blue carbon stocks and change). With the new emphasis on synergistic approaches to the identification and conservation of both carbon- and species- rich habitats, we need much better knowledge of the geography and status of blue carbon habitats beyond coastal wetlands. In subpolar and polar regions, some blue carbon habitats are still emerging and work as negative (mitigating) feedback on climate change, yet remain unprotected despite strong evidence of threat overlap. Scientific research expeditions are gradually increasing our understanding, but appropriate vessels are a limiting factor due to high costs and carbon footprints. Even when available such vessels cannot access all areas (e.g., remote fjords with sills) and may struggle to measure certain aspects of habitats (e.g., steep or vertical surfaces). New technologies and opportunities have advanced to aid some of these problems, and here, two of them are considered, mini-manned submersibles and autonomous underwater vehicles. These two platforms have both become much more available and affordable (through novel partnerships) while also being much more scientifically capable. This technology has the potential to reduce the carbon footprint of science and particularly aid in assessing biology and environment status and change on steep sides, such as fjord walls
Carbon-based materials: adsorptive removal of antibiotics from water
No full textThe contamination generated by multiple antibiotics represents a general concern given its impact at the environmental level, mainly affecting the planet’s soil and water and impacting the development of numerous species. Additionally, a new problem has been triggered in terms of the development of antibiotic-resistance genes in various pathogenic microorganisms generating concern for the health sector in terms of the efficiency of antibiotics in the future. These actual problems and concerns demand efforts and actions to remove or eliminate these contaminants. Multiple alternatives to reduce the impact of antibiotics in water have been carried out, such as advanced oxidation, reverse osmosis, and membrane filtration. However, adsorption techniques have presented more favorable and viable results in which carbon-based materials are an efficient tool to remediate the environment that can take advantage of other alternatives due to their characteristics. This review presents different carbon-based absorptive materials such as biochar, carbon nanotubes, activated carbon, and graphene to remove these contaminants, given their characteristics and favorable results. However, process integration, production, and modification continue to be challenging and require more research and experimentation
New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers
No full textThe clinical treatment of DNA-repair defective tumours has been revolutionised by the use of poly(ADP) ribose polymerase (PARP) inhibitors. However, the efficacy of these compounds is hampered by resistance, which is attributed to numerous mechanisms including rewiring of the DNA damage response to favour pathways that repair PARP inhibitor-mediated damage. Here, we comment on recent findings by our group identifying the lysine methyltransferase SETD1A as a novel factor that conveys PARPi resistance. We discuss the implications, with a particular focus on epigenetic modifications and H3K4 methylation. We also deliberate on the mechanisms responsible, the consequences for the refinement of PARP inhibitor use in the clinic, and future possibilities to circumvent drug resistance in DNA-repair deficient cancers
Concomitant medications and circulating tumor cells: friends or foes?
No full textThe use of concomitant medications by patients with cancer is observed almost globally; however, little attention has been paid to this topic in the medical literature. Most clinical studies do not describe the type and duration of drugs used at the time of inclusion and during treatment or how these drugs may affect the experimental and/or standard therapy. Even less information has been published on the potential interaction between concomitant medications and tumor biomarkers. However, we do know that concomitant drugs can complicate cancer clinical trials and biomarker development, thus contributing to their interaction, leading to side effects, and resulting in suboptimal adherence to anticancer treatment. On the basis of these premises and moving from the study by Jurisova et al., which reported the effect of commonly used drugs on the prognosis of women with breast cancer and the detection of circulating tumor cells (CTCs), we comment on the role of CTCs as an emerging diagnostic and prognostic tool for breast cancer. We also report the known and hypothesized mechanisms of CTC interplay with other tumor and blood components, possibly modulated by widespread drugs, including over-the-counter compounds, and discuss the possible implications of commonly used concomitant medications on CTC detection and clearance. After considering all these points, it is conceivable that concomitant drugs are not necessarily a problem, but on the contrary, their virtuous mechanisms can be exploited to reduce tumor spread and enhance the effect of anticancer therapies
Data sources:
Access Repository Dashboard
Do you manage OAE Publishing (via Crossref)? Access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard!